Last quote by Andy Slavitt
Andy Slavitt quotes
Overall, there is significant growth in spending on prescription drugs, representing a significant burden. In 2015, total prescription drug costs were estimated to have been $457 billion, or 16.7 percent of personal health care spending. That is up from $367 billion, or 15.4 percent of personal health care spending in 2012.
Half of the physician practices under 10 (doctors) will not be reporting at all.
Transforming something of this size is something we have focused on with great care.
This law and this regulation are going to need to evolve as medicine evolves.
After rebates, net Medicaid spending over this five-year period was approximately $797 million, reflecting a rebate of 13 percent.
This incorrect classification has financial consequences for the amount that federal and state governments spend because it reduces the amount of quarterly rebates Mylan owes for EpiPen.
Ensuring access to high quality patient care is a top priority for us. We are concerned about reports that some organizations may be engaging in enrollment activities that put their profit margins ahead of their patients' needs. These actions can limit benefits for those who need them, potentially result in greater costs to patients, and ultimately increase the cost of [Obamacare] marketplace coverage for everyone.
This progress is occurring while also helping more Americans get coverage, often for the first time.